Avascular necrosis prevention with lipitor in lupus erythematosus.
Belmont
H M
HM
Lydon
E
E
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D004311:Double-Blind Method; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D010020:Osteonecrosis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D011758:Pyrroles / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin